Carrageenin-induced arthritis: V. A morphologic study of the development of inflammation in acute arthritis.
Following a single injection of the polysaccharide carrageenin into the rabbit knee joint, a rapid inflammatory process occurs in the joint space and synovial membrane, followed by changes in the articular cartilage. Initially there is an influx of cells, mainly PMNs, into the synovial fluid, accompanied by proliferation of the synovial lining cells and infiltration of the synovial membrane. The numbers of synovial fluid cells decline gradually after 24 hr. The reaction in the synovial membrane is greatest at day 7, and inflammation is still evident at day 21. Initially, the infiltrate consists mainly of PMNs, but by day 7 it is predominantly mononuclear, with small clusters of lymphocytes. The articular cartilage shows loss of metachromasia with toluidine blue at 3-14 days after injection, but stains normally after day 21. Electron microscopy shows damage to the chondrocytes at day 1 and 7, with complete destruction of cells in the surface layer. At day 7 cells in the deeper layers have lost the apparatus required for proteoglycan synthesis, but at day 21 the cells appear virtually normal. There was no evidence for a direct inhibitory effect of carrageenin on proteoglycan biosynthesis. Most labeled carrageenin was rapidly cleared from the joint space, but about 10% was retained in the synovial membrane and 0.6% in articular cartilage at 48 hr after injection. Since the increase and decline in PMN numbers respectively precede the cartilage damage and recovery, it is suggested that there may be a correlation between the clinical activity of arthritis and the number of PMNs in the synovial fluid.
D000818:Animals; D001168:Arthritis / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002351:Carrageenan / Q000378:metabolism / Q000633:toxicity*; D002358:Cartilage, Articular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D005260:Female; D007249:Inflammation / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D007270:Injections, Intra-Articular; D008297:Male; D011817:Rabbits; D013582:Synovial Fluid / Q000166:cytology; D013583:Synovial Membrane / Q000187:drug effects / Q000473:pathology
D002351:Carrageenan